JP2023062064A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023062064A5 JP2023062064A5 JP2023021335A JP2023021335A JP2023062064A5 JP 2023062064 A5 JP2023062064 A5 JP 2023062064A5 JP 2023021335 A JP2023021335 A JP 2023021335A JP 2023021335 A JP2023021335 A JP 2023021335A JP 2023062064 A5 JP2023062064 A5 JP 2023062064A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- substituted
- composition according
- pharmaceutically acceptable
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- DEOUZFWSQWEPGE-UHFFFAOYSA-N 2-methylheptanamide Chemical compound CCCCCC(C)C(N)=O DEOUZFWSQWEPGE-UHFFFAOYSA-N 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- SLOPJPLJISGXPG-UHFFFAOYSA-N bicyclo[2.2.1]heptane-3-carboxamide Chemical compound C1CC2C(C(=O)N)CC1C2 SLOPJPLJISGXPG-UHFFFAOYSA-N 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762517394P | 2017-06-09 | 2017-06-09 | |
| US62/517,394 | 2017-06-09 | ||
| PCT/IB2018/054123 WO2018225009A1 (en) | 2017-06-09 | 2018-06-07 | Compounds and compositions for inducing chondrogenesis |
| JP2019567650A JP7229945B2 (ja) | 2017-06-09 | 2018-06-07 | 軟骨形成を誘導するための化合物及び組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567650A Division JP7229945B2 (ja) | 2017-06-09 | 2018-06-07 | 軟骨形成を誘導するための化合物及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023062064A JP2023062064A (ja) | 2023-05-02 |
| JP2023062064A5 true JP2023062064A5 (enExample) | 2023-07-12 |
| JP7432778B2 JP7432778B2 (ja) | 2024-02-16 |
Family
ID=62837959
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567650A Active JP7229945B2 (ja) | 2017-06-09 | 2018-06-07 | 軟骨形成を誘導するための化合物及び組成物 |
| JP2023021335A Active JP7432778B2 (ja) | 2017-06-09 | 2023-02-15 | 軟骨形成を誘導するための化合物及び組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567650A Active JP7229945B2 (ja) | 2017-06-09 | 2018-06-07 | 軟骨形成を誘導するための化合物及び組成物 |
Country Status (38)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190282A1 (ar) | 2017-06-09 | 2019-12-05 | Novartis Ag | مركبات وتركيبات لحث تكوّن الغضاريف |
| CN113015735B (zh) * | 2018-12-06 | 2024-06-21 | 诺华股份有限公司 | 用于诱导软骨发生以治疗关节损害的5-羟基-7-氧杂双环[2.2.1]庚烷-2-甲酰胺衍生物 |
| CN113015736B (zh) * | 2018-12-06 | 2024-06-21 | 诺华股份有限公司 | 用于诱导软骨发生以治疗关节损害的6-羟基-8-氧杂三环[3.2.1.02,4]辛烷-2-甲酰胺衍生物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5131998A (en) * | 1997-01-06 | 1998-08-03 | Pfizer Inc. | Cyclic sulfone derivatives |
| ECSP982358A (es) | 1998-01-06 | 1998-12-22 | Derivados ciclicos de sulfona | |
| US6407250B1 (en) * | 2000-09-14 | 2002-06-18 | Allergan Sales, Inc. | Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| US6369089B1 (en) | 2000-09-14 | 2002-04-09 | Allergan Sales, Inc. | Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| CN1213050C (zh) | 2000-11-23 | 2005-08-03 | 拜尔公司 | 氧杂双环[2.2.1]庚烷衍生物，其制备方法和作为农药的用途 |
| US6653468B1 (en) | 2002-07-31 | 2003-11-25 | Isis Pharmaceuticals, Inc. | Universal support media for synthesis of oligomeric compounds |
| JP2005068052A (ja) | 2003-08-22 | 2005-03-17 | Mitsui Chemicals Inc | 新規なフラン誘導体及びその製造方法 |
| WO2006038112A1 (en) | 2004-10-01 | 2006-04-13 | Warner-Lambert Company Llc | Use of kinase inhibitors to promote neochondrogenesis |
| US7595327B2 (en) * | 2005-03-21 | 2009-09-29 | Wyeth | Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase |
| US9233106B2 (en) | 2006-07-12 | 2016-01-12 | Cornell Research Foundation, Inc. | Inhibition of beta-amyloid peptide aggregation |
| JO3240B1 (ar) | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
| US20100256385A1 (en) | 2009-04-02 | 2010-10-07 | Allergan, Inc. | Prostaglandin e receptor antagonists |
| PL2453921T3 (pl) | 2009-07-14 | 2015-11-30 | Scripps Research Inst | Różnicowanie mezenchymalnych komórek macierzystych |
| CN101628951B (zh) | 2009-08-12 | 2011-06-22 | 中国石油天然气股份有限公司 | 烯烃聚合用固体催化组分及其催化剂 |
| JP5937102B2 (ja) | 2010-12-14 | 2016-06-22 | エレクトロフォレティクス リミテッド | カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤 |
| US9464065B2 (en) | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| WO2012177856A2 (en) | 2011-06-21 | 2012-12-27 | Adispell, Inc. | Cognition modification |
| WO2013007765A1 (en) * | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| KR102283996B1 (ko) | 2013-03-15 | 2021-07-29 | 더 스크립스 리서치 인스티튜트 | 연골형성의 유도를 위한 화합물 및 방법 |
| EP3143026B1 (en) | 2014-05-13 | 2024-07-10 | Novartis AG | Compounds and compositions for inducing chondrogenesis |
| JP2016204316A (ja) | 2015-04-24 | 2016-12-08 | 日東電工株式会社 | 核酸固相合成用リンカー及び担体 |
| JOP20190282A1 (ar) * | 2017-06-09 | 2019-12-05 | Novartis Ag | مركبات وتركيبات لحث تكوّن الغضاريف |
-
2017
- 2017-06-16 JO JOP/2019/0282A patent/JOP20190282A1/ar unknown
-
2018
- 2018-06-05 UY UY0001037759A patent/UY37759A/es active IP Right Grant
- 2018-06-06 AR ARP180101514A patent/AR113227A1/es unknown
- 2018-06-07 HR HRP20240155TT patent/HRP20240155T1/hr unknown
- 2018-06-07 IL IL300755A patent/IL300755A/en unknown
- 2018-06-07 KR KR1020207000290A patent/KR102656524B1/ko active Active
- 2018-06-07 FI FIEP21178695.9T patent/FI3915994T3/fi active
- 2018-06-07 TW TW107119618A patent/TWI782036B/zh active
- 2018-06-07 RS RS20240179A patent/RS65161B1/sr unknown
- 2018-06-07 HU HUE21178695A patent/HUE065194T2/hu unknown
- 2018-06-07 MA MA050547A patent/MA50547A/fr unknown
- 2018-06-07 ES ES21178695T patent/ES2971319T3/es active Active
- 2018-06-07 MY MYPI2019006646A patent/MY198288A/en unknown
- 2018-06-07 LT LTEP21178695.9T patent/LT3915994T/lt unknown
- 2018-06-07 PE PE2019002520A patent/PE20200403A1/es unknown
- 2018-06-07 EA EA201992858A patent/EA201992858A1/ru unknown
- 2018-06-07 WO PCT/IB2018/054123 patent/WO2018225009A1/en not_active Ceased
- 2018-06-07 MX MX2019014757A patent/MX389169B/es unknown
- 2018-06-07 CR CR20190551A patent/CR20190551A/es unknown
- 2018-06-07 US US16/620,407 patent/US11091499B2/en active Active
- 2018-06-07 EP EP21178695.9A patent/EP3915994B9/en active Active
- 2018-06-07 EP EP18737718.9A patent/EP3634967A1/en not_active Withdrawn
- 2018-06-07 PL PL21178695.9T patent/PL3915994T3/pl unknown
- 2018-06-07 PT PT211786959T patent/PT3915994T/pt unknown
- 2018-06-07 CA CA3063985A patent/CA3063985A1/en active Pending
- 2018-06-07 CU CU2019000098A patent/CU24577B1/es unknown
- 2018-06-07 SI SI201831061T patent/SI3915994T1/sl unknown
- 2018-06-07 AU AU2018279306A patent/AU2018279306C1/en active Active
- 2018-06-07 MA MA57022A patent/MA57022B1/fr unknown
- 2018-06-07 BR BR112019025866-3A patent/BR112019025866A2/pt not_active Application Discontinuation
- 2018-06-07 JP JP2019567650A patent/JP7229945B2/ja active Active
- 2018-06-07 CN CN201880037287.1A patent/CN110719913B/zh active Active
- 2018-06-07 EP EP23203447.0A patent/EP4299123A3/en active Pending
- 2018-06-07 DK DK21178695.9T patent/DK3915994T3/da active
-
2019
- 2019-11-06 ZA ZA2019/07358A patent/ZA201907358B/en unknown
- 2019-12-03 IL IL271154A patent/IL271154B2/en unknown
- 2019-12-05 CO CONC2019/0013706A patent/CO2019013706A2/es unknown
- 2019-12-05 SA SA519410729A patent/SA519410729B1/ar unknown
- 2019-12-05 CL CL2019003564A patent/CL2019003564A1/es unknown
- 2019-12-05 EC ECSENADI201986712A patent/ECSP19086712A/es unknown
- 2019-12-05 DO DO2019000305A patent/DOP2019000305A/es unknown
- 2019-12-06 PH PH12019502764A patent/PH12019502764A1/en unknown
-
2021
- 2021-07-06 US US17/368,537 patent/US11753416B2/en active Active
-
2023
- 2023-02-15 JP JP2023021335A patent/JP7432778B2/ja active Active
- 2023-07-18 US US18/354,163 patent/US12209096B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023062064A5 (enExample) | ||
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| RU2315041C2 (ru) | Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения | |
| RU2361860C2 (ru) | Новые замещенные 3-сера-индолы | |
| JP2004506632A5 (enExample) | ||
| JP2006503019A5 (enExample) | ||
| IL264982B (en) | Hetero(aryl)cyclopropylamine compounds as lsd1 inhibitors | |
| JP2005514334A5 (enExample) | ||
| JP2016503786A5 (enExample) | ||
| JP2004504388A5 (enExample) | ||
| RU2014121984A (ru) | Бензолсульфонамидные соединения и их применение в качестве терапевтических средств | |
| JP2005511543A5 (enExample) | ||
| JP2004504301A5 (enExample) | ||
| JP2016506964A5 (ja) | ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド | |
| RU2018104868A (ru) | 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 | |
| JP2005536475A5 (enExample) | ||
| CA2412968A1 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| RU2010110640A (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| JP2016516028A5 (enExample) | ||
| JP2015514762A5 (enExample) | ||
| RU2015143675A (ru) | Ship1 модуляторы и относящиеся к ним способы | |
| JP2018535235A5 (enExample) | ||
| RU2009148507A (ru) | Производное тетрагидроизохинолин-1-она или его соль | |
| JP2004524279A5 (enExample) |